首页> 外文期刊>British journal of clinical pharmacology >Stem cell therapy for bone repair: a systematic review and meta‐analysis of preclinical studies with large animal models
【24h】

Stem cell therapy for bone repair: a systematic review and meta‐analysis of preclinical studies with large animal models

机译:干细胞疗法进行骨修复:大型动物模型的临床前研究的系统综述和荟萃分析

获取原文
       

摘要

Aim Injury to bone is a significant clinical challenge, due to its limited regenerative capacity. The current methods of repairing bone defect are surgical, highly invasive and not always successful. A systematic review and meta-analysis of preclinical studies involving large animals with bone defects were conducted to determine the treatment outcomes with stem cell therapies. Methods A random effects meta-analysis of the available studies was conducted to assess the treatment outcomes including the rate of new bone formation and new bone mineral density (BMD). Stratified analyses were also conducted by separating studies based on each characteristic independently. Results Pooled analysis of 20 preclinical studies showed a significant beneficial effect of stem cell therapy in increasing new bone formation (17.79%, 95% confidence interval [CI], 10.54, 25.03; P ?2, 95% CI, 62.71, 491.17; P 7 vs . ≥107; P = 0.048) and the route of cell delivery (combining with matrix scaffold showed more effect than direct cell injection, P = 0.041). The effect of stem cell therapy diminished after 12 weeks. Conclusion The study results suggest that stem cell therapy improves new bone formation and BMD in bone defect models. Future trials should focus on the transplantation of ≥107 stem cells, especially using slow release biodegradable scaffolds or repetitive cell injections.
机译:目的由于骨骼的再生能力有限,因此对骨骼的伤害是一项重大的临床挑战。当前修复骨缺损的方法是外科手术,高度侵入性的并且并不总是成功的。对涉及患有骨缺损的大型动物的临床前研究进行了系统的回顾和荟萃分析,以确定干细胞疗法的治疗结果。方法对现有研究进行随机效应荟萃分析,以评估治疗结果,包括新骨形成率和新骨矿物质密度(BMD)。通过根据每个特征独立地分离研究,也进行了分层分析。结果对20项临床前研究的汇总分析显示,干细胞疗法在增加新骨形成方面具有显着的有益效果(17.79%,95%置信区间[CI],10.54,25.03; P?2 ,95%CI,62.71)。 ,491.17; P 7 vs.≥10 7 ; P = 0.048)和细胞递送途径(与基质支架组合显示比直接细胞注射更有效,P = 0.041)。 12周后干细胞疗法的效果减弱。结论研究结果表明,干细胞疗法可改善骨缺损模型中的新骨形成和BMD。未来的试验应着重于≥10 7 干细胞的移植,特别是使用缓慢释放的可生物降解支架或重复性细胞注射。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号